The R and D strength of Neiss Labs and the ability to develop strategic alliances in terms of in-licensing agreements is the cornerstone of a large product pipeline. This is a key component of the business strategy of the company which will enable the company to have a sustainable and long term competitive advantage.
Indian manufacturers are one of the lowest cost producers of drugs in the world. With a scalable labor force, indian manufacturers can produce drugs at 40% to 50% of the cost to the rest of the world. In some cases, this cost is as low as 90%.
More details:View company website
Its Free
Verify Now
